THE IDEA
New company deploying a technology platform for large scale at home collection and subsequent curation and analysis of a wide range of data modalities—phenotypic, traditional biophysical markers, omics data and digital biomarkers. Essentially building a human health passport by combining digital and biophysical biomarkers.
THE TECHNOLOGY
Platform will initially be used (i) as part of a public-private initiative to capture data on 5 million UK NHS patients—10 biophysical and digital modalities, genetics, blood and patient health records, and (ii) for the Multiomic clinical studies. Sanome will eventually license the platform or establish product development partnerships with a wide range of biopharma, medtech, healthcare payer and healthcare provider organizations.